RESUMEN
Objective: To observe the clinical efficacy of row needling at the Governor Vessel on the head for poststroke insomnia, analyze the changes of sleep structure, serum amino acid neurotransmitters, vascular endothelial cell function and cognitive function, in order to explore the mechanism of this therapy.Methods: A total of 41 patients with poststroke insomnia were included in an observation group and treated with row needing at the Governor Vessel on the head; 33 patients with poststroke insomnia were included in a control group and given routine acupuncture treatment. The patients in both groups were treated consecutively for one month. The efficacy was observed and the changes of related indicators were compared. Results: After treatment, the efficacy of the observation group was better than that of the control group (P<0.05). The sleep latency in the observation group was shorter than that in the control group (P<0.05); the total sleep duration, deep sleep duration, light sleep duration and rapid eye movement sleep duration in the observation group were significantly longer than those in the control group (P<0.05); the total waking duration and the waking times over 5 min were significantly less than those in the control group (P<0.05). The serum glutamic acid, γ-aminobutyric acid, calcitonin gene-related peptide, brain-derived neurotrophic factor, nerve growth factor and nitric oxide levels were significantly higher than those in the control group (P<0.01). The tumor necrosis factor-α, interleukin-6, bradykinin, and endothelin-1 levels were lower than those in the control group (P<0.01). The Pittsburgh sleep quality index score in the observation group was lower than that in the control group (P<0.01), and the mini-mental state examination score was higher than that in the control group (P<0.05). Conclusion: Row needling at the Governor Vessel on the head can effectively improve the sleep structure, cognitive function, and sleep quality of patients with poststroke insomnia. The possible mechanisms are regulating serum amino acid neurotransmitters and improving the function of vascular endothelial cells.
RESUMEN
OBJECTIVE: To investigate the effects of acupuncture with dexamethasone (A. Dex) on allergic rhinitis (AR) by injecting dexamethasone into the Zusanli (ST 36) acupoint. METHODS: Thirty 6-week-old female BALB/c mice were sensitized on days 1, 5, and 14 by intraperitoneal injection of 100 µg of ovalbumin (OVA). The mice were then randomly divided into six groups (n = 5 in each group). Five groups were sensitized intranasally with 2 µL of 1.5 mg of OVA for 10 consecutive days, while one group was sensitized intranasally with PBS in a similar manner as a negative control group. One hour before each administration of intranasal OVA, two groups were orally administered either a control vehicle (distilled water; AR control group) or 200 µg/kg Dex (O. Dex group), while three groups received A. Dex at Zusanli (ST 36) with Dex concentrations of 2, 20, and 200 µg/kg for each group, respectively. AR symptoms were evaluated by measuring the rubbing score, which comprised the number of nose, ear, and eye rubs that occurred in the initial 10 min after OVA intranasal provocation on the 10th day. We isolated spleen, serum, and nasal mucosal tissue after measuring the rubbing score. Spleen weight was measured using an electronic microbalance. The levels of IgE, thymic stromal lymphopoietin, tumor necro- sis factor-α, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2 in serum or nasal mucosal tissue were measured using enzyme-linked immunosorbent assays. The serum histamine levels of OVA-sensitized AR mice were measured using O-phthaldialdehyde spectrofluorometry. Western blot analysis was performed on nasal mucosal tissue extracts. RESULTS: A. Dex significantly reduced the rubbing score, spleen weight, serum IgE, and serum histamine in OVA-sensitized mice. A. Dex significantly decreased the serum levels of inflammatory cytokines (thymic stromal lymphopoietin and tumor ne- crosis factor-α) in OVA-sensitized mice. A. Dex sig-nificantly reduced the nasal mucosal levels of inflammatory markers (intercellular adhesion molecule-1andmacrophage-inflammatory protein-2) inAR mice. A. Dex effectively attenuated the expression of caspase-1 and receptorinteractingprotein-2 in nasal mucosal tissue.
Asunto(s)
Puntos de Acupuntura , Dexametasona/uso terapéutico , Ovalbúmina/toxicidad , Rinitis Alérgica/inducido químicamente , Rinitis Alérgica/tratamiento farmacológico , Acupuntura , Animales , Caspasa 1/metabolismo , Citocinas/sangre , Citocinas/metabolismo , Femenino , Molécula 1 de Adhesión Intercelular/sangre , Molécula 1 de Adhesión Intercelular/metabolismo , Ratones , Ratones Endogámicos BALB C , Mucosa Nasal/efectos de los fármacos , Mucosa Nasal/metabolismo , Rinitis Alérgica/sangre , Rinitis Alérgica/metabolismo , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/metabolismo , Linfopoyetina del Estroma TímicoRESUMEN
A rapid method for the simultaneous determination of berberine (BBR), matrine (MT) and oxymatrine (OMT) by nonaqueous capillary electrophoresis (NACE) was developed. Optimum separation of the analytes was obtained on a 50cm×50μm i.d. fused-silica capillary using a non-aqueous buffer system of 70mM ammonium acetate, 7.0% acetic acid and 10% acetonitrile at 25kV and 20℃. The relative standard deviations (R.S.D.) of the migration times and peak areas of the three active components were 0.06%-0.20% and 0.12%-3.41% for berberine, 0.11%-0.60% and 0.74%-1.63% for matrine, 0.15% and 0.45% for oxymatrine, respectively. Detection limits of berberine, matrine and oxymtrine were 0.18μg/mL, 4.08μg/mL and 4.16μg/mL, respectively. In the tested concentration range, good linear relationships (0.9992 for berberine, 0.9988 for matrine and 0.9988 for oxymatrine) were observed. The linear calibration ranges were 0.45-360.0μg/mL for berberine, 8.16-408.0μg/mL for matrine and 20.8-416.0μg/mL for oxymatrine. This method has been successfully applied to the phytochemical analysis of alkaloids extracts from two commonly used traditional Chinese herbal drugs: Sophora flavescens Ait. (Kushen) and Cortex phellodendri chinensis (Huangbai) and their medicinal preparations.